132 related articles for article (PubMed ID: 9532158)
1. Pravastatin and low-dose cyclosporine treatment prevent islet allograft rejection in mice.
Arita S; Kasraie A; Une S; Ohtsuka S; Atiya A; Shevlin L; Mullen Y
Transplant Proc; 1998 Mar; 30(2):522. PubMed ID: 9532158
[No Abstract] [Full Text] [Related]
2. Prolongation of islet allograft survival in mice by combined treatment with pravastatin and low-dose cyclosporine.
Arita S; Kasraie A; Une S; Ohtsuka S; Smith CV; Mullen Y
Cell Transplant; 2001; 10(7):639-44. PubMed ID: 11714199
[TBL] [Abstract][Full Text] [Related]
3. Pravastatin prevents primary nonfunction of canine islet autografts.
Arita S; Nagai T; Ochiai M; Sakamoto Y; Smith CV; Shevlin L; Mullen Y
Transplant Proc; 1998 Mar; 30(2):411. PubMed ID: 9532104
[No Abstract] [Full Text] [Related]
4. Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function.
Xin MJ; Cui SH; Liu S; Sun HC; Li F; Sun JB; Luo B
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):312-8. PubMed ID: 20525560
[TBL] [Abstract][Full Text] [Related]
5. Islet graft primary nonfunction and its prevention.
Arita S; Smith CV; Nagai T; Sakamoto Y; Maruyama M; Mullen Y
Transplant Proc; 2000 Nov; 32(7):1667. PubMed ID: 11119883
[No Abstract] [Full Text] [Related]
6. Prevention of early loss of transplanted islets in the liver of mice by adenosine.
Nitta T; Itoh T; Matsuoka N; Mera T; Kojima D; Nakano M; Yamashita Y; Yasunami Y
Transplantation; 2009 Jul; 88(1):49-56. PubMed ID: 19584680
[TBL] [Abstract][Full Text] [Related]
7. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
[TBL] [Abstract][Full Text] [Related]
8. 15-Deoxyspergualin prolongs pancreatic islet allo- and xenograft survival in mice.
Sandberg JO; Korsgren O; Groth CG; Andersson A
Pharmacol Toxicol; 1993 Jul; 73(1):24-8. PubMed ID: 8234187
[TBL] [Abstract][Full Text] [Related]
9. Prolongation of murine islet allograft survival by pretreatment of islets with 2-chloroadenosine.
Takeda Y; Satomi S; Miura S; Koja S; Morimoto K; Okazaki H; Taguchi Y; Mori S
Transplant Proc; 1993 Feb; 25(1 Pt 2):971-2. PubMed ID: 8442285
[No Abstract] [Full Text] [Related]
10. Low energy X-ray (grenz ray) treatment of purified islets prior to allotransplant markedly decreases passenger leukocyte populations.
Pawlick R; Gala-Lopez B; Pepper AR; Abualhassan N; Bruni A; Suzuki K; Rayat G; Elliott JF; Shapiro AMJ
Islets; 2017 Jul; 9(4):e1330742. PubMed ID: 28692319
[TBL] [Abstract][Full Text] [Related]
11. Effect of concanavalin A on mouse islet cell transplantation.
Zhu XY; He J; Yang PA
Transplant Proc; 1987 Feb; 19(1 Pt 2):954-6. PubMed ID: 3152647
[No Abstract] [Full Text] [Related]
12. Prevention of islet allograft rejection in diabetic mice by targeting Janus Kinase 3 with 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline (JANEX-1).
Cetkovic-Cvrlje M; Dragt AL; Uckun FM
Arzneimittelforschung; 2003; 53(9):648-54. PubMed ID: 14558439
[TBL] [Abstract][Full Text] [Related]
13. Acceptance of intrahepatic islet allografts without immunosuppression in the limited strain combination of mice from C57BL/6 to BALB/c.
Nagai T; Yasunami Y; Ikehara Y; Kodama S; Maki T; Ikeda S
Transplant Proc; 1998 Mar; 30(2):418. PubMed ID: 9532107
[No Abstract] [Full Text] [Related]
14. Ingested interferon-alpha prevents allograft islet transplant rejection.
Brod SA; Katz S; Phan T; Stepkowski S
Transplantation; 2000 May; 69(10):2162-6. PubMed ID: 10852617
[TBL] [Abstract][Full Text] [Related]
15. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting.
Wang H; Hosiawa KA; Min W; Yang J; Zhang X; Garcia B; Ichim TE; Zhou D; Lian D; Kelvin DJ; Zhong R
J Immunol; 2003 Oct; 171(7):3823-36. PubMed ID: 14500684
[TBL] [Abstract][Full Text] [Related]
16. Extended functional survival of murine islet allografts with 15-deoxyspergualin.
Kaufman DB; Field MJ; Gruber SA; Farney AC; Stephanian E; Gores PF; Sutherland DE
Transplant Proc; 1992 Jun; 24(3):1045-7. PubMed ID: 1604510
[No Abstract] [Full Text] [Related]
17. The effect of HMG-CoA reductase inhibitors on chronic allograft rejection.
Katznelson S
Contrib Nephrol; 1997; 120():97-104. PubMed ID: 9257052
[No Abstract] [Full Text] [Related]
18. Potent immunosuppressive effect of anti-LFA-1 monoclonal antibody on islet allograft rejection.
Nishihara M; Gotoh M; Fukuzaki T; Ohta Y; Monden M; Yagita H; Okumura K; Miyasaka M; Mori T
Transplant Proc; 1995 Feb; 27(1):372. PubMed ID: 7879025
[No Abstract] [Full Text] [Related]
19. A Novel Subcutaneous Site of Islet Transplantation Superior to the Liver.
Yasunami Y; Nakafusa Y; Nitta N; Nakamura M; Goto M; Ono J; Taniguchi M
Transplantation; 2018 Jun; 102(6):945-952. PubMed ID: 29521877
[TBL] [Abstract][Full Text] [Related]
20. Immunohistological study of islet xenograft rejection in immunosuppressed recipients.
Andereggen E; Bühler L; Fournier B; Deng S; Bubloz C; Morel P
Transplant Proc; 1996 Apr; 28(2):826-8. PubMed ID: 8623420
[No Abstract] [Full Text] [Related]
[Next] [New Search]
